APA

Banfield C., Scaramozza M., Zhang W., Kieras E., Page K. M., Fensome A., Vincent M., Dowty M. E., Goteti K., Winkle P. J. & Peeva E. (20190503). The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis. : Journal of clinical pharmacology.

Chicago

Banfield Christopher, Scaramozza Matthew, Zhang Weidong, Kieras Elizabeth, Page Karen M, Fensome Andrew, Vincent Michael, Dowty Martin E, Goteti Kosalaram, Winkle Peter J and Peeva Elena. 20190503. The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis. : Journal of clinical pharmacology.

Harvard

Banfield C., Scaramozza M., Zhang W., Kieras E., Page K. M., Fensome A., Vincent M., Dowty M. E., Goteti K., Winkle P. J. and Peeva E. (20190503). The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis. : Journal of clinical pharmacology.

MLA

Banfield Christopher, Scaramozza Matthew, Zhang Weidong, Kieras Elizabeth, Page Karen M, Fensome Andrew, Vincent Michael, Dowty Martin E, Goteti Kosalaram, Winkle Peter J and Peeva Elena. The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis. : Journal of clinical pharmacology. 20190503.